Postdoctoral Fellow at New York Medical College, United States
Dr. Anish R. Maskey is a dedicated postdoctoral fellow at the Department of Pathology, Microbiology & Immunology at New York Medical College, with a specialized focus on allergy, immunology, and infectious diseases. With an in-depth understanding of translational research, he integrates bench-to-bedside approaches, concentrating on biomarker discovery, immune response profiling, and therapeutic evaluation for allergic and inflammatory conditions. Over the past six years, he has built a strong scientific portfolio in both academic and clinical research settings, with active involvement in designing, executing, and analyzing preclinical studies using in-vitro systems, human samples, and murine models. His collaborative nature and leadership skills are evident through his mentorship of over 25 trainees, active role in multi-institutional conferences, and contribution to peer-reviewed journals. Dr. Maskey’s publication record includes multiple first-author and collaborative studies in prominent journals like Frontiers in Allergy, Cells, and The Journal of Inflammation Research. His scientific acumen is matched by his commitment to education and community-building in science. As a member of multiple professional societies and editorial boards, he continues to shape the future of immunological research while fostering international collaboration and integrative medical approaches. His work represents a blend of scientific excellence, innovation, and societal impact.
Professional Profile
Education
Dr. Anish R. Maskey holds a Ph.D. in Pathology, Microbiology, and Immunology from New York Medical College, which he earned in 2023 with a commendable CGPA of 3.75/4. His doctoral research was centered on discovering small molecule compounds—particularly from Traditional Chinese Medicine—as novel therapeutics for eosinophilic esophagitis. This body of work laid the foundation for his expertise in allergic diseases, immunomodulation, and translational medicine. Prior to his Ph.D., Dr. Maskey completed his Bachelor of Science in Medical Laboratory Technology from the Institute of Medicine in Kathmandu, Nepal, graduating in 2016 with a strong academic record of 72%. His educational journey reflects a continual evolution from clinical laboratory sciences to cutting-edge immunological research, underpinned by rigorous training in microbiology, molecular biology, and clinical diagnostics. Beyond formal education, he has also actively pursued professional development through certifications in clinical trial ethics, laboratory safety, peer reviewing, and biomedical research compliance under platforms such as CITI and Elsevier. These educational milestones not only showcase Dr. Maskey’s technical proficiency but also his commitment to lifelong learning, scientific integrity, and the ethical conduct of human and animal research. His academic background enables him to operate seamlessly at the intersection of clinical science and laboratory innovation.
Professional Experience
Dr. Maskey currently serves as a postdoctoral fellow at New York Medical College, where he works under the mentorship of Dr. Xiu-Min Li on multiple NIH-funded projects related to allergic diseases, microbiome therapy, and drug discovery. He is the Co-Investigator or Co-Principal Investigator on several high-impact translational research studies involving human clinical samples and murine models. His work explores the therapeutic efficacy of natural compounds on conditions such as eczema, food allergies, eosinophilic esophagitis, and antibiotic-resistant infections. Previously, during his Ph.D. candidacy (2018–2023), he led key investigations on chronic inflammatory diseases and mentored junior researchers while also teaching advanced immunology and microbiology courses. Dr. Maskey has authored or co-authored over 15 peer-reviewed publications and actively contributes as an editorial board member and peer reviewer for journals such as Frontiers in Allergy and The FASEB Journal. In his leadership roles, he has managed research teams, coordinated research conferences, and overseen protocol development and compliance for IRB and IACUC projects. His professional experience reflects a dynamic integration of teaching, research, mentorship, and administration, underlining his preparedness for independent academic or industry-based scientific leadership roles in immunology, microbiology, and translational medicine.
Research Interests
Dr. Anish R. Maskey’s research interests span allergy and immunology, host-pathogen interactions, microbiome-based therapy, and immune modulation using natural compounds. His primary focus lies in discovering and validating biomarkers for allergic diseases, including food allergies, eczema, eosinophilic esophagitis, and drug-resistant infections. Dr. Maskey is particularly interested in translational and integrative approaches to treating chronic inflammation by bridging clinical medicine with basic science. Through his ongoing work on immune profiling, he explores cytokine signaling, IgE-mediated hypersensitivity, mast cell activation, and epigenetic regulation of Th2 responses. He has established various murine models for food allergies, eczema, and Staphylococcus aureus infections to test the efficacy and mechanisms of plant-based therapeutics like berberine and ganoderic acid. Additionally, he investigates the skin and gut microbiomes’ roles in disease progression and recovery, utilizing both in-vivo and ex-vivo models. His interest also extends to nanoparticle drug delivery and immune memory formation. Dr. Maskey’s ultimate goal is to facilitate the development of safer, non-steroidal treatment options that are effective, personalized, and rooted in natural product pharmacology. His work contributes meaningfully to both the scientific community and clinical practice, offering promising alternatives for managing and preventing allergic and inflammatory disorders.
Awards and Honors
Dr. Anish R. Maskey has been the recipient of numerous prestigious awards and honors recognizing his academic excellence, innovative research, and impactful scientific contributions. He has won multiple travel scholarships from the American Academy of Allergy, Asthma & Immunology (AAAAI) from 2022 to 2025, allowing him to present his research at major national conferences. In 2023, he received the APFED travel grant and earned the Outstanding Abstract Award at Touro Research Day in 2024. He also secured second place for oral abstract presentation at the 1st PMI Conference at New York Medical College and was a runner-up in the ASBMB’s “Science in a Flash” competition. His publications have gained recognition as Top Cited and Top Downloaded articles by WILEY and The FASEB Journal. Furthermore, Dr. Maskey has been appointed as an Editorial Board Member for the International Journal of Infectious Diseases and Therapy and The FASEB Journal’s Early Career Researcher Board. His service as a peer reviewer for journals under Cell Press, Frontiers, MDPI, and Dove Medical Press further underscores his credibility and scientific leadership. These accolades collectively affirm his rising influence in the fields of immunology and translational medicine.
Conclusion
Dr. Anish R. Maskey is an outstanding candidate for the Best Researcher Award, especially in the category of early-career/postdoctoral researchers. His contributions to the fields of immunology and infectious diseases are substantive, innovative, and multidisciplinary. His leadership in research, commitment to mentoring, and active scholarly engagement make him exceptionally deserving of recognition.
Publications Top Notes
-
Title: A small molecule compound berberine as an orally active therapeutic candidate against COVID‐19 and SARS
First Author: Wang ZZ
Year: 2021
Citations: 68
-
Title: Cytochrome P450 3A4 suppression by epimedium and kaempferol leads to synergistic anti-inflammatory effect with corticosteroid
First Author: Li K
Year: 2023
Citations: 12
-
Title: Inhibition of pathologic immunoglobulin E in food allergy by EBF-2 and berberine with immunometabolism regulation
First Author: Yang N
Year: 2023
Citations: 11
-
Title: Induction of severe eosinophilic esophagitis and multi-organ inflammation by airborne allergens
First Author: Maskey A
Year: 2022
Citations: 9
-
Title: Formononetin inhibits B cell-IgE production by regulating XBP-1
First Author: Yang N
Year: 2023
Citations: 7
-
Title: Anti-IgE effect of arctigenin on food allergy with a distinct transcriptome profile
First Author: Cao M
Year: 2022
Citations: 6
-
Title: Computational analysis of 7,4’-Dihydroxyflavone on eosinophilic esophagitis
First Author: Maskey AR
Year: 2022
Citations: 3
-
Title: Efficacy of Ganoderic Acid C1 on corticosteroid-resistant neutrophilic airway inflammation
First Author: Wang ZZ
Year: 2024
Citations: 2
-
Title: Berberine inhibits inflammatory response by S. aureus in atopic eczema
First Author: Maskey AR
Year: 2024
Citations: 2
-
Title: Potency and chemical consistency of FAHF-2 for food allergy treatment
First Author: Maskey A
Year: 2020
Citations: 2
-
Title: The gut microbiome and cross-reactivity of food allergens
First Author: Taico Oliva C
Year: 2025
Citations: 1
-
Title: Preclinical models of atopic dermatitis for therapeutic investigations
First Author: Maskey AR
Year: 2024
Citations: 1
-
Title: Berberine’s potential in attenuating S. aureus-induced inflammation
First Author: Kwan M
Year: 2024
Citations: 1
-
Title: 7,4 Dihydroxy Flavone for treatment of eosinophilic esophagitis
First Author: Maskey AR
Year: 2022
Citations: 1
-
Title: Biomarkers and neurobiomarkers in allergic contact dermatitis
First Author: Sasaki A
Year: 2025
Citations: Not listed
-
Title: Roles of bitter and sweet taste receptors in food allergy
First Author: Xian M
Year: 2025
Citations: Not listed